galactose has been researched along with ro13-9904 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fatemi, I; Hakimizadeh, E; Hassanshahi, J; Kaeidi, A; Nematollahi, MH; Rahmani, M; Taghipour, Z | 1 |
1 other study(ies) available for galactose and ro13-9904
| Article | Year |
|---|---|
Ceftriaxone improves hepatorenal damages in mice subjected to D-galactose-induced aging.
Topics: Aging; Animals; Ceftriaxone; Galactose; Hepatorenal Syndrome; Inflammation; Kidney; Liver; Male; Mice; Oxidation-Reduction; Oxidative Stress | 2020 |